Results 1 to 10 of about 18,628 (194)
Some of the next articles are maybe not open access.
Morbidity of cytoreductive surgery in the elderly
American Journal of Obstetrics and Gynecology, 2004While ovarian cancer is often seen in elderly patients, such women are often not treated as aggressively as younger patients. In this study, we evaluated the feasibility and morbidity of cytoreductive surgery in the elderly.A retrospective review was performed of all patients with epithelial ovarian carcinoma who underwent exploratory laparotomy ...
Jason D, Wright +2 more
openaire +2 more sources
Cytoreductive surgery for ovarian cancer
European Journal of Surgical Oncology (EJSO), 2003The aim of this study is to describe the technique of managing peritoneal dissemination in patients with ovarian cancer, based on radical surgical excision and, later, perioperative chemotherapy.Treatments included complete surgical resection of the peritoneal disease, and intraperitoneal intraoperative and postoperative chemotherapy, using Adriamycin ...
D M, Kecmanovic +4 more
openaire +2 more sources
Patient Selection for Cytoreductive Surgery
Surgical Oncology Clinics of North America, 2018The peritoneal malignancies span the biologic spectrum of aggressiveness from the indolent growth pattern and superficial nature of well-differentiated mucinous appendiceal adenocarcinoma to the rapidly growing and invasive nature of poorly differentiated signet ring cell adenocarcinomas of the appendix, colon, and stomach.
Travis E, Grotz +2 more
openaire +2 more sources
Technical aspects of cytoreductive surgery
Journal of Surgical Oncology, 2008AbstractAt the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Five conflicting points were discussed: radicality of the peritonectomy procedure, cytoreduction of neoplastic nodules <2 ...
Shigeki, Kusamura +4 more
openaire +2 more sources
Surgery, gynecology & obstetrics, 1990
The results of experimental studies suggest that cytoreduction has important potential benefits. In the laboratory setting, reduction of tumor burden increases the sensitivity of remaining tumor to chemotherapy and radiation therapy by increasing the proportion of proliferating tumor cells, by decreasing the number of necessary chemotherapeutic cycles ...
R J, Wong, J J, DeCosse
openaire +1 more source
The results of experimental studies suggest that cytoreduction has important potential benefits. In the laboratory setting, reduction of tumor burden increases the sensitivity of remaining tumor to chemotherapy and radiation therapy by increasing the proportion of proliferating tumor cells, by decreasing the number of necessary chemotherapeutic cycles ...
R J, Wong, J J, DeCosse
openaire +1 more source
Cytoreductive Surgery in Ovarian Carcinoma
Obstetrics & Gynecology, 1986Between 1974 and 1984, 70 patients underwent primary cytoreductive surgery for ovarian carcinoma at the University of California at Los Angeles. During the period of January 1974 to December 1978, optimal cytoreduction was achieved in 56.4% of the patients.
A P, Heintz +5 more
openaire +2 more sources
SECONDARY CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER
Obstetrics and Gynecology Clinics of North America, 1994Secondary cytoreduction to optimal levels can be successfully accomplished in a substantial number of ovarian cancer patients and in a variety of clinical settings. Although frequently complex, secondary operations can be performed with acceptable morbidity. All operations should be undertaken by experienced oncologic surgeons.
T W, Burke, M, Morris
openaire +2 more sources
CUSA splenorrhaphy for ovarian cytoreductive surgery
Gynecologic Oncology, 1991Abstract Use of the CUSA to resect splenic capsular metastases from ovarian adenocarcinoma is a viable surgical alternative to splenectomy for achieving optimal cytoreductive surgery.
B, Patsner, P G, Rose
openaire +2 more sources
Advanced Cytoreductive Surgery Workshop Report
International Journal of Gynecological Cancer, 2012The Advanced Course in Cytoreductive Surgery for Ovarian Cancer and Gynecologic Peritoneal Surface Malignancies was held at the University of California Irvine Medical Center on November 4-5, 2011. The course director was Dr Robert E. Bristow, the Philip J. DiSaia Chair and Division Director of Gynecologic Oncology.
openaire +2 more sources
Ovarian Cancer Cytoreductive Surgery in the Elderly
Current Treatment Options in Oncology, 2009Patient selection for cytoreductive surgery is a critical clinical assessment that defines the early management of ovarian cancer, and standardized patient-selection criteria for debulking surgery are lacking. The term "elderly" has been variably defined in the ovarian cancer debulking literature as being older than age 60, 70, or 80+ years of age ...
openaire +2 more sources